Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 389, Issue 3, 2016, Pages 349-352

  Klotz, Karl Norbert ^a   Kachler, Sonja ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adenosine receptor; Adenylyl cyclase; Inhibitor; Selectivity

Indexed keywords

2 AMINO 7 (2 FURYL) 7,8 DIHYDRO 5(6H) QUINAZOLINONE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE RECEPTOR; ADENYLATE CYCLASE INHIBITOR; NB 001; UNCLASSIFIED DRUG; VIDARABINE; 5-​((2-​(6-​AMINO-​9H-​PURIN-​9-​YL)​ETHYL)​AMINO)​-​1-​PENTANOL; 9-(TETRAHYDRO-2-FURYL)-ADENINE; ADENINE; ADENOSINE TRIPHOSPHATE;

ARTICLE; CROSS REACTION; DRUG STRUCTURE; INVESTIGATIVE PROCEDURES; ANALOGS AND DERIVATIVES; ANIMAL; CELL MEMBRANE; CHO CELL LINE; CRICETULUS; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM;

ADENINE; ADENOSINE TRIPHOSPHATE; ADENYLYL CYCLASE INHIBITORS; ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETULUS; HUMANS; RECEPTORS, PURINERGIC P1; TRANSFECTION; VIDARABINE;

EID: 84957844412     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-015-1197-z     Document Type: Article

References (19)

1. Brand CS, Hocker HJ, Gorfe AA, Cavasetto CN, Dessauer CW (2013) Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds. J Pharmacol Exp Ther 347:265-275
2. Dal Ben D, Buccioni M, Lambertucci C, Kachler S, Falgner N, Marucci G, Thomas A, Cristalli G, Volpini R, Klotz K-N (2014) Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch. 87:321-331
3. De Lorenzo MS, Chen W, Baljinnyam E, Carlini MJ, La Perle K, Bishop SP, Wagner TE, Rabson AB, Vatner DE, Puricelli LI, Vatner SF (2013) Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption. Aging Cell 13:102-110
4. Fredholm BB, IJzerman AP, Jacobson KA, Klotz K-N, Linden J (2001) International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552
5. Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Muller CE (2011) International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev 63:1-34
6. 2A receptor. Part 5: highly bio-available pyrimidine-4-carboxamides. Bioorg Med Chem Lett 19:2664-2667
7. Inamdar GS, Pandya AN, Thakar HM, Sudarsanam V, Kachler S, Sabbadin D, Moro S, Klotz K-N, Vasu KK (2013) New insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamides. Eur J Med Chem 63:924-934
8. 3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 385:519-525
9. Klotz K-N (2000) Adenosine receptors and their ligands. Naunyn-Schmiedeberg's Arch Pharmacol 362:382-391
10. Klotz K-N, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedeberg's Arch Pharmacol 357:1-9
11. 3 receptor. Eur J Pharmacol 556:14-18
12. 2A receptor structures reveal common features of GPCR activation. Nature 474:524-525
13. 6-cyclohexyladenosine: an adenosine derivative with antagonist properties at adenosine receptors. Eur J Pharmacol 156:157-160
14. Matos MJ, Vilar S, Kachler S, Celeiro M, Vazquez-Rodriguez S, Santana L, Uriarte E, Hripcsak G, Borges F, Klotz K-N (2015) Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold. Bioorg Chem 61:1-6
15. Pierre S, Eschenhagen T, Geisslinger G, Scholich K (2009) Capturing adenylyl cyclases as potential drug targets. Nat Rev Drug Discov 8:321-335
16. Seifert R (2014) Vidarabine is neither a potent nor a selective AC5 inhibitor. Biochem Pharmacol 87:543-546
17. Seifert R, Lushington GH, Mou T-C, Gille A, Sprang SR (2012) Inhibitors of membranous adenylyl cyclases. Trends Pharmacol Sci 33:64-78
18. 1 receptor ligands. Curr Top Med Chem 3:355-367
19. Vatner SF, Park M, Yan L, Lee GJ, Lai L, Iwatsubo K, Ishikawa Y, Pessin J, Vatner DE (2013) Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging. Am J Physiol Heart Circ Physiol 305:H1-H8